Hypogonadism as a consequence of craniopharyngioma in female patients: comparison of childhood and adult onset and effects of estrogen replacement therapy
- PMID: 38761348
- DOI: 10.1007/s12020-024-03872-7
Hypogonadism as a consequence of craniopharyngioma in female patients: comparison of childhood and adult onset and effects of estrogen replacement therapy
Abstract
Purpose: (1) to compare clinical, biochemical features in female patients with hypoestrogenism due to childhood- and adult-onset CP; (2) to reveal effects of estrogen replacement therapy in female patients with childhood-onset CP.
Methods: Thirty-seven women that received specific treatment for CP in the period from 1980 to 2019 were recruited: 21 with childhood-onset and 16 with adult-onset CP. Clinical and hormonal characteristics were evaluated. Seventeen-beta-estradiol 2 mg and dydrogesterone 10 mg in sequential regiment was used in 18 childhood-onset cases. Mean follow-up was 31 months.
Results: Amenorrheic women with childhood- and adult-onset CP presented with the same complaints except for lack of genital hair and breast hypoplasia, which were common in patients with childhood-onset CP. BMI was lower in childhood-onset CP group, as was the proportion of overweight patients. They had more favorable lipid profile. The levels of estradiol, testosterone and DHEA-S were low and did not differ. Uterine and ovary volumes were reduced in all patients, but the decline was noticeable in the childhood-onset group. Mineral bone density of lumbar vertebrae was diminished in childhood-onset group. Estrogen therapy in these patients led to clinical improvement: increase in BMD in lumbar spine without negative changes in BMI and/or lipid profile.
Conclusions: Study showed that women with childhood-onset CP had less negative metabolic changes. However, they have more pronounced breast and uterus hypoplasia and lower BMD in lumbar spine. The estrogen replacement therapy led to clinical improvement and BMD increase in lumbar spine without increase of BMI and/or lipid profile changes.
Keywords: Central Hypogonadism; Craniopharyngioma; Estrogen Replacement Therapy; Females; Hypoandrogenism.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Factors of mineral homeostasis impairment and bone mineral density loss in women with central hypogonadism.Climacteric. 2020 Dec;23(6):597-602. doi: 10.1080/13697137.2020.1767567. Epub 2020 Jun 10. Climacteric. 2020. PMID: 32519580
-
Hypothalamic involvement and insufficient sex steroid supplementation are associated with low bone mineral density in women with childhood onset craniopharyngioma.Eur J Endocrinol. 2011 Jul;165(1):25-31. doi: 10.1530/EJE-11-0229. Epub 2011 Apr 18. Eur J Endocrinol. 2011. PMID: 21502326
-
Effects of Hormone Replacement Therapy on Low Bone Mineral Density in Adolescents and Young Women with Hypogonadism: Comparison of Oral and Transdermal 17 Beta-Estradiol Administration.J Pediatr Adolesc Gynecol. 2022 Dec;35(6):634-637. doi: 10.1016/j.jpag.2022.05.004. Epub 2022 May 26. J Pediatr Adolesc Gynecol. 2022. PMID: 35644512
-
Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.Drugs Aging. 1997 Oct;11(4):309-32. doi: 10.2165/00002512-199711040-00006. Drugs Aging. 1997. PMID: 9342560 Review.
-
Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults.J Pediatr. 1995 May;126(5 Pt 1):683-9. doi: 10.1016/s0022-3476(95)70393-4. J Pediatr. 1995. PMID: 7751989 Review.
References
-
- D.N. Louis, A. Perry, P. Wesseling, D.J. Brat, I.A. Cree, D. Figarella-Branger, C. Hawkins et al. The 2021 WHO classification of tumors of the central nervous system: A Summary. Neuro-Oncol. 23(8), 1231–1251 (2021). https://doi.org/10.1093/neuonc/noab106 - DOI - PubMed - PMC
-
- N. Karavitaki, C. Brufani, J.T. Warner, C.B.T. Adams, P. Richards, O. Ansorge, B. Shine, H.E. Turner, J.A.H. Wass, Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin. Endocrinol. 62(4), 397–409 (2005). https://doi.org/10.1111/j.1365-2265.2005.02231.x - DOI
-
- M.J. Diaz, S.H. Kwak, K.T. Root, A. Fadil, A. Nguyen, L. Ladehoff, S. Batchu, B. Lucke-Wold, Current approaches to craniopharyngioma management. Front. Biosci. (Landmark Ed.) 27(12), 328 (2022). https://doi.org/10.31083/j.fbl2712328 - DOI - PubMed
-
- E.M. Erfurth, Endocrine aspects and sequel in patients with craniopharyngioma. J. Pediatr. Endocrinol. Metab.: JPEM 28(1–2), 19–26 (2015). https://doi.org/10.1515/jpem-2014-0419 - DOI - PubMed
-
- A.M. Pereira, E.M. Schmid, P.J. Schutte, J.H.C. Voormolen, N.R. Biermasz, S.W. van Thiel, E.P.M. Corssmit, J.W.A. Smit, F. Roelfsema, J.A. Romijn, High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin. Endocrinol. 62(2), 197–204 (2005). https://doi.org/10.1111/j.1365-2265.2004.02196.x - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous